Weili Yang
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Gastroenterology top 5%
- Gastrointestinal Tumor Research and Treatment
Papers in
-
- Circular RNAs in diseases 7
- RNA modifications and cancer 7
- Surgery 28
- Pancreatic function and diabetes 9
- Gastrointestinal disorders and treatments 9
- Co-authors
- Jichun Yang (19 shared papers)Qinghua Cui (11 shared papers)Yuhong Meng (10 shared papers)Zhenzhen Chen (8 shared papers)Jin‐Kui Yang (8 shared papers)Junpei Wang (9 shared papers)Miaomiao Zhao (2 shared papers)Wei Hou (1 shared paper)
- Journals
- Scandinavian Journal of Gastroenterology (5 papers)Clinical Epigenetics (3 papers)Diabetes (3 papers)European Journal of Pharmacology (3 papers)Oncotarget (3 papers)
- Partner nations
- ChinaUnited StatesRomania
In The Last Decade
Weili Yang
105 papers receiving 2.0k citations
Weili Yang's Hit Papers
Peers
Comparison fields: 5 of 138
- Cancer Research 422
- Gastroenterology 122
- Infectious Diseases 265
- Molecular Biology 898
- Immunology 200
Countries citing papers authored by Weili Yang
This map shows the geographic impact of Weili Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weili Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weili Yang more than expected).
Fields of papers citing papers by Weili Yang
This network shows the impact of papers produced by Weili Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weili Yang. The network helps show where Weili Yang may publish in the future.
Co-authors
The 25 scholars most cited alongside Weili Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 110 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Cathepsin L plays a key role in SARS-CoV-2 infection in humans and humanized mice and is a promising target for new drug development Hit paper breakdown → | 2021 | 330 |
| 2 | 2013 | 117 | |
| 3 | 2018 | 98 | |
| 4 | 2018 | 89 | |
| 5 | 2015 | 78 | |
| 6 | 2017 | 73 | |
| 7 | 2018 | 60 | |
| 8 | 2017 | 54 | |
| 9 | 2019 | 48 | |
| 10 | 2015 | 42 | |
| 11 | 2009 | 41 | |
| 12 | 2015 | 40 | |
| 13 | 2018 | 40 | |
| 14 | 2017 | 35 | |
| 15 | 2017 | 35 | |
| 16 | 2014 | 34 | |
| 17 | 2019 | 33 | |
| 18 | 2024 | 31 | |
| 19 | 2016 | 31 | |
| 20 | 2017 | 29 |
About Weili Yang
Weili Yang is a scholar working on Molecular Biology, Surgery, Cancer Research, Pulmonary and Respiratory Medicine and Gastroenterology, having authored 110 papers that have together received 2.1k indexed citations. Recurring topics across this work include Gastrointestinal Tumor Research and Treatment (14 papers), Cancer-related molecular mechanisms research (13 papers), MicroRNA in disease regulation (11 papers), Gastric Cancer Management and Outcomes (10 papers), Pancreatic function and diabetes (9 papers), Gastrointestinal disorders and treatments (9 papers), Circular RNAs in diseases (7 papers) and RNA modifications and cancer (7 papers). The work is most often cited by research in Cancer Research (422 citations), Gastroenterology (122 citations), Infectious Diseases (265 citations), Molecular Biology (898 citations) and Immunology (200 citations). Weili Yang has collaborated with scholars based in China, United States and Romania. Frequent co-authors include Jichun Yang, Qinghua Cui, Yuhong Meng, Zhenzhen Chen, Jin‐Kui Yang, Junpei Wang, Miaomiao Zhao, Wei Hou, Yingmei Feng and Fangyuan Yang. Their work appears in journals such as Scandinavian Journal of Gastroenterology, Clinical Epigenetics, Diabetes, European Journal of Pharmacology and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.